Miwa, Keisuke Oki, Eiji Enomoto, Masanobu Ihara, Keisuke Ando, Koji Fujita, Fumihiko Tominaga, Masahiro Mori, Shinichiro Nakayama, Goro Shimokawa, Mototsugu
...
Published in
BMC Cancer
BackgroundPreoperative chemoradiotherapy (CRT), the current standard of care for locally advanced rectal cancer (LARC), is associated with many radiotherapy (RT)-related side effects. We aimed to evaluate whether S-1 and oxaliplatin (SOX) or folinic acid, 5-FU, and oxaliplatin (mFOLFOX6) can be as effective as neoadjuvant chemotherapy (NAC) regimen...
Rallis, Kathrine S Lai Yau, Thomas Ho Sideris, Michail
Published in
Anticancer research
Chemoradiotherapy (CRT) refers to the combined administration of both chemotherapy and radiotherapy as an anticancer treatment. Over the years, CRT has become an established treatment for a diverse range of locally advanced solid tumours. The rationale for CRT is based on the two concepts of spatial cooperation and in-field cooperation, whereby the...
Sakin, A Sahin, S Atci, M M Sakin, A Yasar, N Geredeli, C Aksaray, F Cihan, S
Published in
Pulmonology
The aim of this study is to investigate the effect of treatment modalities on survival among unoperat ed and locally-advanced non-small cell lung cancer (NSCLC) patients aged 70 years and older, representing real-life data. From 2005 through 2017, medical records of 2259 patients with lung cancer from Okmeydani Training and Research Hospital-Istanb...
Kakeji, Yoshihiro Oshikiri, Taro Takiguchi, Gosuke Kanaji, Shingo Matsuda, Takeru Nakamura, Tetsu Suzuki, Satoshi
Published in
Esophagus : official journal of the Japan Esophageal Society
Esophageal cancer has a poor prognosis despite the fact that surgical techniques have been advanced and optimized, and systemic multimodality approaches have progressed recently. Adding chemotherapy, radiotherapy, and immunotherapy to the basic surgical approach have been shown to have therapeutic benefit for esophageal cancer. This review describe...
Watanabe, Masayuki Tachimori, Yuji Oyama, Tsuneo Toh, Yasushi Matsubara, Hisahiro Ueno, Masaki Kono, Koji Uno, Takashi Ishihara, Ryu Muro, Kei
...
Published in
Esophagus : official journal of the Japan Esophageal Society
Esophageal cancer is the eighth most common cause of cancer mortality in Japan. More than 11,000 people had died from esophageal cancer in 2018. The Japan Esophageal Society has collected the data on patients' characteristics, performed treatment, and outcomes annually. We analyzed the data of patients who had first visited the participating hospit...
Lerman, Jacques Hennequin, Christophe Etienney, Isabelle Abramowitz, Laurent Goujon, Gael Gornet, Jean-Marc Guillerm, Sophie Aparicio, Thomas Valverde, Alain Cattan, Pierre
...
Published in
European journal of cancer (Oxford, England : 1990)
Anal squamous cell carcinoma is associated with multiple risk factors, including infection with human papillomavirus and human immunodeficiency virus, immunosuppression, multiple sex partners, receptive anal sex and tobacco smoking. The aim of our study was to identify prognostic factors associated with poor outcomes after radiotherapy for anal can...
Limonnik, Vladimir Abel, Stephen Finley, Gene G Long, Gregory S Wegner, Rodney E
Published in
Lung cancer (Amsterdam, Netherlands)
Large cell neuroendocrine carcinoma (LCNEC) is a rare pulmonary malignancy with clinicopathologic features of both non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Given the paucity of available data regarding LCNEC management, we queried the National Cancer Database (NCDB) to describe trends in management, identify predictors ...
Salazar, Ramón Capdevila, Jaume Manzano, Jose Luis Pericay, Carles Martínez-Villacampa, Mercedes López, Carlos Losa, Ferrán Safont, María José Gómez-España, Auxiliadora Alonso-Orduña, Vicente
...
Published in
BMC Cancer
BackgroundPreoperative chemoradiotherapy with capecitabine is considered as a standard of care for locally advanced rectal cancer. The “Tratamiento de Tumores Digestivos” group (TTD) previously reported in a randomized Ph II study that the addition of Bevacizumab to capecitabine-RT conferred no differences in the pre-defined efficacy endpoint (path...
Mukai, Yuki Hayashi, Yuichiro Koike, Izumi Koizumi, Toshiyuki Sugiura, Madoka Oguri, Senri Takano, Shoko Kioi, Mitomu Sato, Mizuki Mitsudo, Kenji
...
Published in
BMC Cancer
BackgroundWe compared outcomes and toxicities between concurrent retrograde super-selective intra-arterial chemoradiotherapy (IACRT) and concurrent systemic chemoradiotherapy (SCRT) for gingival carcinoma (GC).MethodsWe included 84 consecutive patients who were treated for non-metastatic GC ≥ stage III, from 2006 to 2018, in this retrospective anal...
Spinler, Kyle Bajaj, Jeevisha Ito, Takahiro Zimdahl, Bryan Hamilton, Michael Ahmadi, Armin Koechlein, Claire S Lytle, Nikki Kwon, Hyog Young Anower-E-Khuda, Ferdous
...
Intratumoral heterogeneity is a common feature of many myeloid leukemias and a significant reason for treatment failure and relapse. Thus, identifying the cells responsible for residual disease and leukemia re-growth is critical to better understanding how they are regulated. Here, we show that a knock-in reporter mouse for the stem cell gene Musas...